Aclaris Therapeutics Eulerpool naujienos

Aclaris Therapeutics akcijų naujienos

Aclaris Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Aclaris Therapeutics naujienas mes pateikiame čia.

• birželio 26 d. ·

  Yahoo
  Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
• birželio 23 d. ·

  Yahoo
  Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
• birželio 2 d. ·

  Yahoo
  Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
• gegužės 10 d. ·

  Yahoo
  Aclaris Therapeutics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
• balandžio 29 d. ·

  Yahoo
  Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
• balandžio 25 d. ·

  Yahoo
  Strong week for Aclaris Therapeutics (NASDAQ:ACRS) shareholders doesn't alleviate pain of three-year loss
• balandžio 22 d. ·

  Yahoo
  Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
• kovo 4 d. ·

  Yahoo
  Aclaris Therapeutics to Participate in Two March Healthcare Conferences
• kovo 4 d. ·

  Yahoo
  Aclaris Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
• vasario 27 d. ·

  Yahoo
  Aclaris: Q4 Earnings Snapshot